Literature DB >> 26001920

Diversion of prescription stimulant drugs among 10-18-year-olds.

Sonam O Lasopa1, Catherine W Striley, Linda B Cottler.   

Abstract

PURPOSE OF REVIEW: Public health concern regarding the nonmedical use of prescription stimulants among youth has generated the need for increased understanding of diversion, which is the illegal sharing and selling of prescription drugs. Although our understanding of nonmedical use of stimulants has increased, the same cannot be said of diversion behavior among youth. RECENT
FINDINGS: The aim of this article is to use data from the National Monitoring of Adolescent Prescription Stimulants Study, which assessed prescription stimulant use among 10-18 years old across 10 US cities to report on prescription stimulant diversion among those who misused those medications. Findings indicate that more than one half (52%) of youth had engaged in one of the three forms of diversion (incoming only, outgoing only and both incoming and outgoing diversion). Engaging in incoming diversion only and both incoming and outgoing diversion increased with age and nonmedical use of prescription stimulants. All forms of diversion increased with marijuana use and among 16-18 years old with a friend's use of prescription stimulant.
SUMMARY: Findings provide an understanding of the subtypes of diversion and risk correlates of youth prescription stimulant diverter's that has value in preventing prescription stimulant diversion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26001920     DOI: 10.1097/YCO.0000000000000172

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  8 in total

1.  Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training.

Authors:  Brooke S G Molina; Heidi L Kipp; Heather M Joseph; Stacey A Engster; Seth C Harty; Montaya Dawkins; Rachel A Lindstrom; Daniel J Bauer; Srihari S Bangalore
Journal:  Acad Pediatr       Date:  2019-06-08       Impact factor: 3.107

2.  Nonmedical Prescription Stimulant Use Among Girls 10-18 Years of Age: Associations With Other Risky Behavior.

Authors:  Catherine Woodstock Striley; Natalie E Kelso-Chichetto; Linda B Cottler
Journal:  J Adolesc Health       Date:  2016-12-18       Impact factor: 5.012

3.  Effects of Training on Use of Stimulant Diversion Prevention Strategies by Pediatric Primary Care Providers: Results from a Cluster-Randomized Trial.

Authors:  Elizabeth A McGuier; David J Kolko; Sarah L Pedersen; Heidi L Kipp; Heather M Joseph; Rachel A Lindstrom; Daniel J Bauer; Geetha A Subramaniam; Brooke S G Molina
Journal:  Prev Sci       Date:  2022-08-11

4.  Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019.

Authors:  Amy R Board; Gery Guy; Christopher M Jones; Brooke Hoots
Journal:  Drug Alcohol Depend       Date:  2020-09-15       Impact factor: 4.492

5.  Changes in Provider Type and Prescription Refills Among Privately Insured Children and Youth With ADHD.

Authors:  Laura C Hart; Scott D Grosse; Melissa L Danielson; Rebecca A Baum; Alex R Kemper
Journal:  J Atten Disord       Date:  2020-09-18       Impact factor: 3.256

6.  Use of Stimulant Diversion Prevention Strategies in Pediatric Primary Care and Associations With Provider Characteristics.

Authors:  Elizabeth A McGuier; David J Kolko; Heather M Joseph; Heidi L Kipp; Rachel A Lindstrom; Sarah L Pedersen; Geetha A Subramaniam; Brooke S G Molina
Journal:  J Adolesc Health       Date:  2021-01-11       Impact factor: 5.012

7.  Adolescents Treated for Attention-Deficit/Hyperactivity Disorder in Pediatric Primary Care: Characterizing Risk for Stimulant Diversion.

Authors:  Brooke S G Molina; Heather M Joseph; Heidi L Kipp; Rachel A Lindstrom; Sarah L Pedersen; David J Kolko; Daniel J Bauer; Geetha A Subramaniam
Journal:  J Dev Behav Pediatr       Date:  2021-09-01       Impact factor: 2.988

Review 8.  Prescription Drug Misuse: Taking a Lifespan Perspective.

Authors:  Ty S Schepis; Dalton L Klare; Jason A Ford; Sean Esteban McCabe
Journal:  Subst Abuse       Date:  2020-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.